SNDX — Syndax Pharmaceuticals Inc. stock price and chart

Share this page

SNDX

$12.90-5.49%

as of close, Oct 16, 2026

☾ AH $12.90 -5.49%

Syndax Pharmaceuticals Inc.Stock · HealthcareRussell 2000 0.06%Nasdaq Composite 0.005%US Stock Market 0.003%Russell 3000 0.002%

PeersMRNALLYMDTUNHJNJTMO

Technical analysis2

Overlay lines0

Addendum charts0

VolumeEEEE

20162019202120242026

5.010.015.020.025.0020.0M$12.90

2026-10-16

Price$12.90

MA20$19.54

MA50$19.37

Vol18.8M

What would $1,000 invested in SNDX be worth today? →

SNDX returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $12.90
YTD price return: -38.60%
YTD total return: -38.60%
Next earnings: Nov 2, 2026
Market cap: 1.2B2016-12 130.4M2026-10 1.2B+784.1% over the window
Enterprise value: 955.6M
Shares outstanding: 89.3M2016-06 17.8M2026-06 89.3M+402.2% over the window
52W low: $12.82
52W high: $25.59
From 52W high: -49.59%
From 52W low: +0.66%
52W range: 1%

Volume

Rel volume: 1.37×
30D volume: 2.1M
30D $ vol: 35M

Fundamentals

Sales (ttm): 252.3M2016-06 1.2M2026-06 252.3M+20576.3% over the window
Sales/share: $2.822016-06 $0.072026-06 $2.82+4017.4% over the window
EPS (ttm): -$2.522019-12 -$1.842026-06 -$2.52+36.8% over the window
FCF (ttm): -323.2M2015-12 -2.5M2025-12 -323.2M+12946.7% over the window
FCF/share: -$3.622015-12 -$0.142025-12 -$3.66+2530.4% over the window
Book value/share: $0.172016-06 $5.972026-06 $0.17-97.2% over the window
Net margin: -87.52%2016-06 -2596.9%2026-06 -87.5%-96.6% over the window
ROE: -1462.12%2016-06 -29.8%2026-06 -1462.1%+4803.0% over the window
ROA: -31.37%2016-06 -24.8%2026-06 -31.4%+26.6% over the window
Current ratio: 6.772016-06 19.442026-06 6.77-65.2% over the window

Growth (CAGR, ttm) · 10Y

Sales: +222.91%2025-06-30 → 2026-06-3078.2M → 252.3M (+222.7% total)n/a+178.12%2021-06-30 → 2026-06-301.5M → 252.3M (+16528.3% total)+70.44%2016-06-30 → 2026-06-301.2M → 252.3M (+20576.3% total)
Shares: +3.67%2025-06-30 → 2026-06-3086.1M → 89.3M (+3.7% total)+8.72%2023-06-30 → 2026-06-3069.5M → 89.3M (+28.5% total)+12.93%2021-06-30 → 2026-06-3048.6M → 89.3M (+83.6% total)+17.52%2016-06-30 → 2026-06-3017.8M → 89.3M (+402.2% total)

Per-share growth (CAGR, ttm) · 10Y

Sales/share: +211.50%2025-06-30 → 2026-06-30$0.91 → $2.82 (+211.3% total)n/a+146.28%2021-06-30 → 2026-06-30$0.03 → $2.82 (+8955.1% total)+45.04%2016-06-30 → 2026-06-30$0.07 → $2.82 (+4017.4% total)
Book value/share: -90.76%2025-06-30 → 2026-06-30$1.83 → $0.17 (-90.7% total)-69.14%2023-06-30 → 2026-06-30$5.76 → $0.17 (-97.1% total)-47.92%2021-06-30 → 2026-06-30$4.41 → $0.17 (-96.2% total)-29.99%2016-06-30 → 2026-06-30$5.97 → $0.17 (-97.2% total)
Price: -14.29%2025-10-16 → 2026-10-16$15.05 → $12.90 (-14.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+1.77%2023-10-16 → 2026-10-16$12.24 → $12.90 (+5.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-7.04%2021-10-15 → 2026-10-16$18.59 → $12.90 (-30.6% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-1.01%2016-10-14 → 2026-10-16$14.28 → $12.90 (-9.7% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: -14.29%2025-10-16 → 2026-10-16$15.05 → $12.90 (-14.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+1.77%2023-10-16 → 2026-10-16$12.24 → $12.90 (+5.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-7.04%2021-10-15 → 2026-10-16$18.59 → $12.90 (-30.6% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-1.01%2016-10-14 → 2026-10-16$14.28 → $12.90 (-9.7% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: -5.1×2016-12 -3.352026-10 -5.22+55.9% over the window
Fwd P/E: -19.9×
P/S (ttm)Market cap ÷ TTM revenue.: 4.6×2016-12 106.922026-10 4.57-95.7% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 76.3×2016-12 1.392026-10 76.38+5394.3% over the window
EV/Sales (ttm): 3.8×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: -28.05%2016-09 -22.5%2025-12 -17.4%-22.4% over the window
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 89.3M ÷ 86.1M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: -3.67%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-3.67%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($806.7M). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: -3.67%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($0) ÷ today's market cap ($1.2B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 0.00%2016-09 0.0%2026-06 0.0%
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $0 + TTM dividends $0) ÷ today's market cap ($1.2B). Same caveat as the cash buyback yield.: 0.00%2016-09 0.0%2026-06 0.0%

Vs own 10Y history

P/S: 0th
P/B: 97th

Bar = where today’s multiple sits in SNDX’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-16#

-5.49%

-24.07%

-25.35%

-43.20%

YTD

-38.60%

-14.29%

-30.61%

Financial statements

Open full SNDX financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+10.48%	+0.43%
JNJ	Johnson & Johnson	-4.38%	+0.90%
ABBV	AbbVie Inc.	+8.73%	+0.71%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	+6.97%	-1.29%
MRK	Merck & Co. Inc.	+0.72%	+0.52%
NVS	Novartis AG	+8.59%	+0.16%
TMO	Thermo Fisher Scientific Inc.	+6.41%	-0.93%
AMGN	Amgen Inc.	+14.92%	-0.35%

SNDX — Syndax Pharmaceuticals Inc. price, chart and key statistics